0.9403
price down icon10.45%   -0.1097
after-market 시간 외 거래: .92 -0.0203 -2.16%
loading
전일 마감가:
$1.05
열려 있는:
$1.04
하루 거래량:
2.71M
Relative Volume:
0.62
시가총액:
$135.41M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.6965
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-5.97%
1개월 성능:
+111.54%
6개월 성능:
+196.72%
1년 성능:
-88.53%
1일 변동 폭
Value
$0.9202
$1.06
1주일 범위
Value
$0.9202
$1.19
52주 변동 폭
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
명칭
Applied Therapeutics Inc
Name
전화
212-220-9226
Name
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
직원
32
Name
트위터
@Applied_Tx
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
APLT's Discussions on Twitter

APLT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APLT
Applied Therapeutics Inc
0.9403 151.21M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-23 다운그레이드 William Blair Outperform → Mkt Perform
2024-12-02 다운그레이드 UBS Buy → Neutral
2024-11-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-07-31 개시 William Blair Outperform
2024-03-26 개시 RBC Capital Mkts Outperform
2024-02-22 개시 Leerink Partners Outperform
2022-01-04 다운그레이드 Barclays Overweight → Equal Weight
2021-08-27 다운그레이드 Goldman Neutral → Sell
2021-06-25 재개 Goldman Neutral
2020-10-08 개시 Truist Buy
2020-04-22 개시 Goldman Buy
2020-02-27 개시 Barclays Overweight
2019-06-10 개시 Citigroup Buy
2019-06-10 개시 Cowen Outperform
2019-06-10 개시 Robert W. Baird Outperform
모두보기

Applied Therapeutics Inc 주식(APLT)의 최신 뉴스

pulisher
Oct 10, 2025

Applied Therapeutics Inc. stock trendline breakdownJuly 2025 EndofMonth & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Applied Therapeutics Inc. hit a new high this monthWeekly Stock Report & High Yield Stock Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Applied Therapeutics Inc. stock reach all time highs in 2025Market Growth Review & AI Driven Price Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to use Fibonacci retracement on Applied Therapeutics Inc.2025 Top Decliners & Verified Stock Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why retail investors favor Applied Therapeutics Inc. stockWeekly Trade Report & Weekly Breakout Watchlists - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Oct 09, 2025
pulisher
Oct 09, 2025

How strong is Applied Therapeutics Inc. stock revenue growthJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Earnings visualization tools for Applied Therapeutics Inc.CPI Data & Accurate Entry and Exit Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Applied Therapeutics Inc. stock benefit from automationJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What drives Applied Therapeutics Inc stock priceAI-Driven Market Analysis & Maximum Profit Growth - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

Is Applied Therapeutics Inc a good long term investmentIPO Market Watch & Budget Friendly Growth Tips - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga

Oct 07, 2025
pulisher
Oct 07, 2025

After losing 87% in the past year, Applied Therapeutics, Inc. (NASDAQ:APLT) institutional owners must be relieved by the recent gain - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

Applied Therapeutics Settled With Investors Over Govorestat FDA Rejection – How to Claim Your Payout - TradingView

Oct 06, 2025
pulisher
Oct 06, 2025

Why Applied Therapeutics Inc. is moving todayEarnings Summary Report & Community Supported Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Applied Therapeutics Inc. continue its uptrendTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Applied Therapeutics Inc. with AIEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How Applied Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Applied Therapeutics Inc. stock near bottom after declineQuarterly Trade Review & Consistent Income Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Institutional investors may adopt severe steps after Applied Therapeutics, Inc.'s (NASDAQ:APLT) latest 19% drop adds to a year losses - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

Custom strategy builders for tracking Applied Therapeutics Inc.Quarterly Risk Review & Expert Curated Trade Setup Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about Applied Therapeutics Inc stockMarket Sentiment Shifts & Optimize Entry & Exit With Smart Signals - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Are Analysts Raising Price Targets for Can Fin Homes Limited AgainValue Stock Picks & Demo Trading Rooms Open Daily - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Oct 01, 2025
pulisher
Oct 01, 2025

How Applied Therapeutics Inc. stock trades during market volatilityGold Moves & Weekly Top Gainers Alerts - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

2025-09-30 | Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | NDAQ:APLT | Press Release - Stockhouse

Sep 30, 2025
pulisher
Sep 30, 2025

Can SMIFS Capital Markets Limited Stock Deliver Alpha in a Choppy MarketCovered Call Writing & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Promising Penny Stocks To Follow Now – September 27th - Defense World

Sep 30, 2025
pulisher
Sep 30, 2025

Applied Therapeutics Inc. $APLT Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Sep 29, 2025
pulisher
Sep 29, 2025

Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Applied Therapeutics Shares Plunge Following FDA Meeting on CMT-SORD Treatment - MSN

Sep 29, 2025

Applied Therapeutics Inc (APLT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Applied Therapeutics Inc 주식 (APLT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Funtleyder Leslie D.
See Remarks
Mar 04 '25
Sale
0.44
14,502
6,381
390,459
Chinoporos Constantine
See Remarks
Mar 04 '25
Sale
0.44
447
197
271,436
Funtleyder Leslie D.
See Remarks
Feb 06 '25
Sale
0.61
22,950
14,000
404,961
Perfetti Riccardo
Chief Medical Officer
Feb 06 '25
Sale
0.61
86,078
52,508
900,775
Chinoporos Constantine
See Remarks
Feb 06 '25
Sale
0.61
28,117
17,151
271,883
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
자본화:     |  볼륨(24시간):